Revive Files IND Application With FDA For Phase 3 Clinical Study For COVID-19 Treatment
Revive Therapeutics (CSE: RVV) announced after the bell today that it has officially filed its investigational new drug (IND) application
Read moreRevive Therapeutics (CSE: RVV) announced after the bell today that it has officially filed its investigational new drug (IND) application
Read moreAs the coronavirus crisis continues to devastate economies around the world, Zimbabwe is facing its own set of austere problems.
Read moreIt appears that yet another blow has been dealt to China. According to a press release issued by India’s government,
Read moreIn response to the unprecedented circumstances posed by the coronavirus pandemic, Cirque du Soleil has been struggling to remain afloat
Read moreAs the demand for crude oil continues to remain low and inventories pile up amid the coronavirus pandemic, many oil
Read moreNot only is the Chinese province of Hubei now infamously known as where the deadly coronavirus originated from, but now
Read moreWelcome back to the Spotlight Series. Today we are looking at SKRR Exploration (TSXV: SKRR), a Saskatchewan based gold explorer.
Read moreHeritage Cannabis (CSE: CANN) this morning announced that it has signed a term sheet for a contract manufacturing agreement with
Read moreFake meat issuer Modern Meat (CSE: MEAT) is expected to commence trading this morning at market open following the completion
Read moreDespite the number of new coronavirus cases in the US continuing to climb, and the unemployment rate being astronomically far
Read more